NCT/Study#

NCT04628767 /

EA8192

A Phase II/III Trial of MEDI4736 (Durvalumab) and Chemotherapy for Patients With High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy

A Phase II/III Trial of MEDI4736 (Durvalumab) and Chemotherapy for Patients With High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy

DISEASE GROUP:
Genito-Urinary
current phase:
Phase II/III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: